Abstract |
Elevation of nonfasting triglyceride (TG) levels above 1.8 g/L (2 mmol/L) is associated with increased risk of cardiovascular diseases. Exacerbated postprandial hypertriglyceridemia (PP-HTG) and metabolic context both modulate the overall efficacy of the reverse cholesterol transport (RCT) pathway, but the specific contribution of exaggerated PP-HTG on RCT efficacy remains indeterminate. Healthy male volunteers (n = 78) exhibiting no clinical features of metabolic disorders underwent a postprandial exploration following consumption of a typical Western meal providing 1200 kcal. Subjects were stratified according to maximal nonfasting TG levels reached after ingestion of the test meal into subjects with a desirable PP-TG response (GLow, TG < 1.8 g/L, n = 47) and subjects with an undesirable PP-TG response (GHigh, TG > 1.8 g/L, n = 31). The impact of the degree of PP-TG response on major steps of RCT pathway, including cholesterol efflux from human macrophages, cholesteryl ester transfer protein (CETP) activity, and hepatic high-density lipoprotein ( HDL)-cholesteryl ester (CE) selective uptake, was evaluated. Cholesterol efflux from human macrophages was not significantly affected by the degree of the PP-TG response. Postprandial increase in CETP-mediated CE transfer from HDL to triglyceride-rich lipoprotein particles, and more specifically to chylomicrons, was enhanced in GHigh vs GLow. The hepatic HDL-CE delivery was reduced in subjects from GHigh in comparison with those from GLow. Undesirable PP-TG response induces an overall reduction in RCT efficacy that contributes to the onset elevation of both fasting and nonfasting TG levels and to the development of cardiometabolic diseases.
|
Authors | Alexandre Motte Motte, Julie Gall Gall, Joe-Elie Salem, Eric Dasque, Martine Lebot, Eric Frisdal, Sophie Galier, Elise F Villard, Elodie Bouaziz-Amar, Jean-Marc Lacorte, Beny Charbit, Wilfried Le Goff, Philippe Lesnik, Maryse Guerin |
Journal | Biomolecules
(Biomolecules)
Vol. 10
Issue 5
(05 25 2020)
ISSN: 2218-273X [Electronic] Switzerland |
PMID | 32466286
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- CETP protein, human
- Cholesterol Ester Transfer Proteins
- Cholesterol Esters
- Chylomicrons
- HDL cholesteryl ester
- Lipoproteins, HDL
- Triglycerides
- Cholesterol
|
Topics |
- Adult
- Cholesterol
(metabolism)
- Cholesterol Ester Transfer Proteins
(metabolism)
- Cholesterol Esters
(metabolism)
- Chylomicrons
(metabolism)
- Humans
- Hypertriglyceridemia
(metabolism)
- Lipoproteins, HDL
(metabolism)
- Liver
(metabolism)
- Macrophages
(metabolism)
- Male
- Postprandial Period
- Triglycerides
(blood, metabolism)
|